Truist Financial raised its price target for Tenet Healthcare, which also filed reports with the Securities and Exchange Commission.
1 report, 1 independent
Updated Jul 29
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
Truist Financial raised its price target for Tenet Healthcare, which also filed reports with the Securities and Exchange Commission.
Who's involved
What this event is mainly aboutKeep exploring
The entities involved
-
Tenet Healthcare
American healthcare company
-
Truist Financial
American bank holding company, formerly known as BB&T Corporation
- MarketBeat aggregates data on Inventiva's stock, and Truist Financial has started coverage of the company.
- Bank of America boosted its price target and gave a buy rating for Guardian Pharmacy Services, Inc. on September 15, 2026. Truist Financial also boosted its target price and gave a buy rating on the same day.
Related events
- Increased holdings in Tenet Healthcare shares requiring SEC filings.
- Treace Medical Concepts disclosed a purchase in an SEC filing, and Truist Financial increased its target price for the company.
- Truist Financial raised its target price on Teva Pharmaceutical Industries Ltd. stock.
- Financial institutions including Truist Financial, Royal Bank of Canada, and Renaissance Technologies issued rating updates and reported institutional holdings changes to the SEC.
- Analyst firms set price targets and issued price objectives for Applied Materials, with company filings reported to the SEC.